Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertugliflozin in T2DM and Hypertension
NCT01096667Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- May 2010
- Primary completion
- Feb 2011
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ertugliflozin in type 2 diabetes mellitus (T2DM), hypertension (HTN), sponsored by Merck & Co.. Started May 2010; status: completed.
02
Drugs
ertugliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)hypertension (HTN)
Beyond the preview
Go deeper on NCT01096667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01096667.